IQVIA Holdings Inc. (NYSE:IQV) Shares Sold by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA cut its holdings in IQVIA Holdings Inc. (NYSE:IQV) by 3.8% in the 3rd quarter, HoldingsChannel reports. The fund owned 134,703 shares of the medical research company’s stock after selling 5,336 shares during the period. Massachusetts Financial Services Co. MA’s holdings in IQVIA were worth $31,921,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. First Foundation Advisors grew its stake in shares of IQVIA by 3.8% during the 2nd quarter. First Foundation Advisors now owns 1,161 shares of the medical research company’s stock valued at $245,000 after buying an additional 43 shares during the period. Invera Wealth Advisors LLC grew its stake in shares of IQVIA by 0.3% during the 2nd quarter. Invera Wealth Advisors LLC now owns 14,506 shares of the medical research company’s stock valued at $3,183,000 after buying an additional 46 shares during the period. Oregon Public Employees Retirement Fund grew its stake in shares of IQVIA by 0.3% during the 2nd quarter. Oregon Public Employees Retirement Fund now owns 15,668 shares of the medical research company’s stock valued at $3,313,000 after buying an additional 48 shares during the period. Continuum Advisory LLC grew its stake in shares of IQVIA by 3.3% during the 2nd quarter. Continuum Advisory LLC now owns 1,538 shares of the medical research company’s stock valued at $325,000 after buying an additional 49 shares during the period. Finally, Clear Harbor Asset Management LLC grew its stake in shares of IQVIA by 1.3% during the 3rd quarter. Clear Harbor Asset Management LLC now owns 3,969 shares of the medical research company’s stock valued at $941,000 after buying an additional 50 shares during the period. 89.62% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on IQV. The Goldman Sachs Group lowered their price objective on shares of IQVIA from $280.00 to $250.00 and set a “buy” rating for the company in a research note on Friday, November 1st. Deutsche Bank Aktiengesellschaft decreased their price target on shares of IQVIA from $270.00 to $265.00 and set a “buy” rating for the company in a research report on Friday, November 1st. TD Cowen decreased their price target on shares of IQVIA from $270.00 to $255.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Truist Financial decreased their price target on shares of IQVIA from $286.00 to $265.00 and set a “buy” rating for the company in a research report on Monday, November 4th. Finally, Evercore ISI decreased their price target on shares of IQVIA from $270.00 to $265.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th. Four research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $256.50.

IQVIA Price Performance

Shares of IQV stock opened at $204.02 on Tuesday. The firm has a fifty day moving average of $221.96 and a two-hundred day moving average of $226.98. The firm has a market cap of $37.03 billion, a P/E ratio of 26.77, a P/E/G ratio of 2.08 and a beta of 1.51. IQVIA Holdings Inc. has a 1-year low of $187.62 and a 1-year high of $261.73. The company has a debt-to-equity ratio of 1.76, a current ratio of 0.81 and a quick ratio of 0.81.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.